Search filters

List of works by Marc Pfister

A Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3‐O‐glucuronide in Renal or Hepatic Impairment ⬇️

scientific article published on May 8, 2013

ACoP: The Tools, Carpenters, and Architects Building the Discipline of Pharmacometrics ⬇️

scientific article published on 01 September 2010

Affiliation between the American Society of Pharmacometrics and the Journal of Pharmacokinetics and Pharmacodynamics ⬇️

scientific article published on February 1, 2012

Causes and Consequences of Variability in Drug Transporter Activity in Pediatric Drug Therapy

scientific article

Characterization of Maternal and Neonatal Pharmacokinetic Behavior of Ceftazidime

scientific article published on 16 August 2018

Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen

scientific article published on 23 July 2021

Defining the Future of Pharmacometrics: The American Society of Pharmacometrics ⬇️

scientific article published on September 1, 2010

Disease Progression Modeling to Evaluate the Effects of Enzyme Replacement Therapy on Kidney Function in Adult Patients with the Classic Phenotype of Fabry Disease

scientific article published on 28 February 2017

Dose evaluation of intravenous metamizole (dipyrone) in infants and children: a prospective population pharmacokinetic study

scientific article published on 07 August 2019

Effect of a high-fat meal on the pharmacokinetics of dapagliflozin, a selective SGLT2 inhibitor, in healthy subjects ⬇️

scientific article published on 01 August 2011

Efficacies of BMS 284756 against Penicillin-Sensitive, Penicillin-Resistant, and Quinolone-Resistant Pneumococci in Experimental Meningitis ⬇️

scientific article published on January 1, 2002

Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning

scientific article published on 31 March 2019

Fostering Culture and Optimizing Organizational Structure for Implementing Model‐Based Drug Development ⬇️

scientific article published on 01 September 2010

Influence of Hepatic Impairment on the Pharmacokinetics and Safety Profile of Dapagliflozin: An Open-Label, Parallel-Group, Single-Dose Study ⬇️

scientific article published on October 26, 2011

Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults

scientific article published on 25 May 2019

Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants

scientific article published on 29 October 2018

Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates

scientific article published on 04 March 2019

Methadone dosing strategies in preterm neonates can be simplified

scientific article published on 10 April 2019

Model-Based Approach for Optimization of Atazanavir Dose Recommendations for HIV-Infected Pediatric Patients ⬇️

scientific article published on September 19, 2011

Model-Based Meta-Analysis for Comparative Efficacy and Safety: Application in Drug Development and Beyond

scientific article published on December 1, 2011

Model-based exposure-response analysis of apixaban to quantify bleeding risk in special populations of subjects undergoing orthopedic surgery

scientific article

Model‐Based Drug Development Survey Finds Pharmacometrics Impacting Decision Making in the Pharmaceutical Industry ⬇️

scientific article published on September 1, 2010

Model‐Based Drug Development: Strengths, Weaknesses, Opportunities, and Threats for Broad Application of Pharmacometrics in Drug Development ⬇️

scientific article published on September 1, 2010

Optimisation of vancomycin exposure in neonates based on the best level of evidence

scientific article published on 18 May 2019

Optimizing Drug Development and Use in Patients With Kidney Disease ⬇️

scientific article published on 01 May 2011

Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK‐875 in Subjects With Type 2 Diabetes Mellitus ⬇️

scientific article published on January 9, 2013

Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis

scientific article published on 17 February 2020

Pharmacometrics-based decision tools facilitate mHealth implementation

scientific article published on 4 November 2016

Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women

scientific article published on 01 January 2020

Pooled model-based approach to compare the pharmacokinetics of entecavir between Japanese and non-Japanese chronic hepatitis B patients ⬇️

scientific article published on 01 May 2011

Quantification of apixaban's therapeutic utility in prevention of venous thromboembolism: selection of phase III trial dose

scientific article published on August 4, 2010

Synergy Between Scientific Advancement and Technological Innovation, Illustrated by a Mechanism‐Based Model Characterizing Sodium‐Glucose Cotransporter‐2 Inhibition ⬇️

scientific article published on 01 September 2010

The Emerging Scientific Discipline of Pharmacometrics ⬇️

scientific article published on 01 September 2010

The influence of kidney function on dapagliflozin exposure, metabolism and pharmacodynamics in healthy subjects and in patients with type 2 diabetes mellitus ⬇️

scientific article published on September 1, 2013

Ultrafiltration rates in children on chronic hemodialysis routinely exceed weight based adult limit

scientific article published on 01 January 2019

Understanding Urea Kinetic Factors That Enhance Personalized Hemodialysis Prescription in Children

scientific article published on 01 January 2020

Understanding and reducing the risk of adverse drug reactions in pediatric patients

scientific article published in January 2015

Paulina is supported by:

About Paulina

Help